Skip to content

1 Year MRI Followup in Facioscapulohumeral Muscular Dystrophy

Disease Progression in Facioscapulohumeral Muscular Dystrophy - 1 Year MRI Follow-up

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02159612
Acronym
FSHD
Enrollment
45
Registered
2014-06-10
Start date
2014-05-31
Completion date
2015-03-31
Last updated
2015-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

FSHD - Facioscapulohumeral Muscular Dystrophy

Keywords

FSHD, MRI, Disease progression

Brief summary

An investigation of disease progression in adult danish patients with facioscapulohumeral muscular dystrophy. The disease progression is followed for a year with two test-days, including functional muscle tests and a MRI scan of muscles in the back and legs.

Detailed description

A cohort of adult danish patients with facioscapulohumeral muscular dystrophy is invited to perform a MRI scan to describe the relation between backpain and disease affection in back muscles. After one year they are re-invited to perform another MRI scan to follow the disease progression. The MRI scan is done to measure the quantity and quality of the muscles in the back, thigh and calf. Further, investigators investigate the muscle function by measuring of muscle strength in legs and in the back together with three functional tests. A walking test (6MWT), a stair test (14SST), and a chair test (5-TSTST). Self-assessment of back pain is measured by a standardized questionnaire about backpain.

Interventions

OTHERMRI

MRI scan of muscles in the back and legs. Including T1, DIXON and STIR images.

Sponsors

Grete Andersen, MD
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed with FSHD type 1

Exclusion criteria

* Pregnant or breastfeeding women. * Patients with claustrophobia. * Patients with implanted metallic parts in the body.

Design outcomes

Primary

MeasureTime frameDescription
Fat infiltration1 yearChange in the distribution of fat infiltration in back, thigh and calves muscles seen at the MRI images.

Secondary

MeasureTime frameDescription
Muscle structure1 yearMuscle structure is evaluated with a four-point semi-quantitative visual scale. Two observers evaluate images independently. Changes in evaluation between 1st and 2nd scan are the outcome measure.
Muscle strength1 yearChanges in muscle strength between 1st. and 2nd MRI-scan.
Back pain1 yearChanges in self-assessed back-pain between 1st. and 2nd scan.
Muscle function1 yearChanges in muscle function between 1st and 2nd MRI-scan, measured by a 6 minute walk test, a 14-step-stair test and a 5-times-sit-to-stand-test.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026